CN Patent

CN116115621A — 氢氯噻嗪组合物及其制备方法及氢氯噻嗪微针透皮贴剂

Assigned to Guangzhou Pengxing Pharmaceutical Technology Co ltd · Expires 2023-05-16 · 3y expired

What this patent protects

本发明提供了一种氢氯噻嗪组合物，包括氢氯噻嗪纳米晶混悬液，所述氢氯噻嗪纳米晶混悬液由氢氯噻嗪原料药和稳定剂组成；其中，氢氯噻嗪纳米晶混悬液中，氢氯噻嗪的药物浓度为10‑100mg/mL，稳定剂的质量体积比例为1％‑3％mg/mL。本发明氢氯噻嗪组合物包括氢氯噻嗪纳米晶混悬液，氢氯噻嗪溶解性高，生物相容好，可用于透皮微针贴剂，利用度高，给药方便。

USPTO Abstract

本发明提供了一种氢氯噻嗪组合物，包括氢氯噻嗪纳米晶混悬液，所述氢氯噻嗪纳米晶混悬液由氢氯噻嗪原料药和稳定剂组成；其中，氢氯噻嗪纳米晶混悬液中，氢氯噻嗪的药物浓度为10‑100mg/mL，稳定剂的质量体积比例为1％‑3％mg/mL。本发明氢氯噻嗪组合物包括氢氯噻嗪纳米晶混悬液，氢氯噻嗪溶解性高，生物相容好，可用于透皮微针贴剂，利用度高，给药方便。

Drugs covered by this patent

Patent Metadata

Patent number
CN116115621A
Jurisdiction
CN
Classification
—
Expires
2023-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Pengxing Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.